Skip to content

Direct-to-biology approach for the selective identification of ligands for alpha-synuclein aggregates

Sep 2026 · ChemRxiv
Parkinson's Disease Mechanisms and Treatments Alzheimer's disease research and treatments

Abstract

The selective targeting of α-synuclein (α-syn) aggregates represents a critical challenge for the diagnosis and treatment of Parkinson’s disease and related synucleinopathies. While several ligands have been developed for amyloid imaging, most of them lack sufficient specificity for α-syn over other amyloid fibrils. We report here a direct-to-biology (D2B) strategy to accelerate the identification of such selective ligands. A library of 384 piperazine-derived compounds was synthesized in a plate-based format and screened to evaluate their affinity for α-syn pathogenic aggregates compared to amyloid-beta 42 (Aβ42) fibrils. Nine compounds were found to bind preferentially to α-syn aggregates, three of which displayed at least a four-fold increased binding compared to Aβ42. Further validation of those molecules using in vitro α-syn fibrils enabled to determine a new potent selective binder of fibrillar α-syn with moderate affinity (181 nM). These findings validate the potential of D2B approaches to accelerate specific ligand development for pathogenic protein aggregates.

View source

Similar papers

#computer vision Review Open access May 2015

A survey study on major technical barriers affecting the decision to adopt cloud services

The comparison of adopter and non-adopter sample reveals three potential adoption inhibitor, security, data privacy, and portability, which underlines the importance of the technical and security perspectives for research investigating the adoption of technology.

Nattakarn Phaphoom, Xiaofeng Wang, S. Samuel et al. · 111 citations · ⚡8
#computer vision Open access Feb 2018

Lean Internal Startups for Software Product Innovation in Large Companies: Enablers and Inhibitors

This study investigates how Lean internal startup facilitates software product innovation in large companies and identifies its enablers and inhibitors, and shows the potential of the method-in-action framework to investigate the Lean startup approach in non-startup context.

Henry Edison, Nina M. Smørsgård, Xiaofeng Wang et al. · 78 citations · ⚡6
#computer vision Book Open access Jul 2015

Understanding the affect of developers: theoretical background and guidelines for psychoempirical software engineering

This paper highlights the challenges to conduct proper affect-related studies with psychology, provides a comprehensive literature review in affect theory, and proposes guidelines for conducting psychoempirical software engineering.

D. Graziotin, Xiaofeng Wang, P. Abrahamsson · 56 citations · ⚡4
#machine learning Open access May 2017

What Influences the Speed of Prototyping? An Empirical Investigation of Twenty Software Startups

This study conducts a multiple case study on twenty European software startups and proposes a prototype-centric learning model in early stage software startups, and identifies factors that occur as barriers but also facilitators for prototyping in earlystage software startups.

Anh Nguyen-Duc, Xiaofeng Wang, P. Abrahamsson · 44 citations · ⚡5
#protein folding Open access Sep 2026

Programmable design of functional proteins from natural language

Pinal, a 16-billion-parameter foundation model that produces protein candidates from natural-language functional descriptions, supports natural language as a high-level interface for candidate generation in protein design, enabling programmable exploration with reduced reliance on manually specified structural or sequence constraints.

Fengyuan Dai, Shiyang You, Yudian Zhu et al. · 31 citations · ⚡3

Related blog posts

MIT News · Artificial Intelligence Aug 27, 2026

Looking beyond natural sequences

A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.

Google DeepMind Blog Nov 25, 2025

AlphaFold: Five years of impact

Explore how AlphaFold has accelerated science and fueled a global wave of biological discovery.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.